Andreas Mackensen

34PUBLICATIONS
171CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

|Feb 05, 2026
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Marco Becilli, Markus Metzler, Claudia Bracaglia

|Jan 07, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial.

Fabian Müller, Melanie Hagen, Andreas Wirsching

|Dec 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data.

Michael I Sponfeldner, Pauline Dürr, Phyllis Lensker

|Jun 12, 2025
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma.

Fabian Müller, Nora Rebecca Schwingen, Melanie Hagen

|May 13, 2025
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment.

Richard J Pelzl, Giulia Benintende, Franziska Gsottberger

Pageof 6

Frequent Collaborators

10 joint publications

Fabian Müller

8 joint publications

Martin Böttcher

7 joint publications

Simon Völkl

6 joint publications

Georg Schett